<DOC>
	<DOCNO>NCT01124396</DOCNO>
	<brief_summary>Investigate safety/tolerability repeat weekly dos intranasal administration DSP-3025 comparator placebo healthy male volunteer</brief_summary>
	<brief_title>DSP-3025 A Phase 1 Study Healthy Male Volunteers</brief_title>
	<detailed_description />
	<criteria>Body mass index ( BMI ) 18.5 25 kg/ m2 weight 50 80 kg No clinically relevant abnormal finding Acute illness require medical intervention Definite suspect personal history adverse drug reaction drug hypersensitivity Clinical relevant disease disorder ( past present ) A history respiratory disorder ( ) asthma</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>39 Years</maximum_age>
	<verification_date>January 2014</verification_date>
</DOC>